János K.
- Country
- Hungary
- Department
- Belgyogyaszat-Immunologiai Ambulancia
Research Overview
- Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study
- Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 213 of 378 partner sites.
Specializations
Lupus Research
This investigator specializes in the treatment of Systemic Lupus Erythematosus (SLE), with particular focus on developing innovative therapies for moderate to severe cases. Their research encompasses the evaluation of novel biological agents including anifrolumab and litifilimab for managing SLE symptoms.
- Moderate-to-severe SLE management
- Novel biological therapeutics
- Long-term disease control strategies
The investigator's work extends to lupus nephritis, exploring targeted treatments for this severe manifestation of lupus affecting the kidneys.
Sjögren's Syndrome Studies
The investigator conducts research in primary Sjögren's Syndrome, focusing on systemic manifestations and innovative therapeutic approaches. Their work includes evaluation of novel compounds like dazodalibep and investigation of treatments for moderate-to-severe disease activity.
- Systemic disease manifestations
- Patient-reported outcomes
- Therapeutic innovation
Their research addresses both systemic complications and symptomatic management of Sjögren's Syndrome.
Therapeutic Development
The investigator is involved in evaluating novel biological agents and delivery systems for autoimmune conditions. Their work includes assessment of various administration methods including subcutaneous delivery systems and different formulations of therapeutic compounds.
- Drug delivery optimization
- Treatment response evaluation
- Long-term safety assessment
Research focuses on developing more effective and convenient treatment options for patients with autoimmune disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.